Oncolytic virus-mediated reducing of myeloid-derived suppressor cells enhances the efficacy of PD-L1 blockade in gemcitabine-resistant pancreatic cancerYoshinori Kajiwara, Toshiyoshi Fujiwara|Cancer Immunology Immunotherapy|2022Cited by 32